AJ12--Development/Production - Kidney GEC-Specific AAV Vector

Estimated Value: $450,000
Open New 13 days left PennsylvaniaInformation Technologyrfi
Oct 21, 2026
Nov 4, 2026 5:00 PM
Information Technology
rfi
541714
small business
AI Summary
This is a Sources Sought/Request for Information notice for the development and production of a kidney glomerular endothelial cell (GEC) specific Adeno Associated Virus (AAV) vector for VA preclinical research. The goal is to create a targeted viral vector to treat kidney injury and disease by incorporating a homing peptide into an AAV capsid. The government is not currently soliciting bids but is gathering information on potential sources.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Development of GEC-Targeting Peptide and Incorporation into AAV Capsid 1 project $150,000.00 $150,000.00 Professional Services
Validation of GEC Targeting Peptide (Phage Display Selection) 1 project $75,000.00 $75,000.00 Professional Services
Feasibility Testing of GEC Specific AAV Vector (In Vitro Culture Studies) 1 project $75,000.00 $75,000.00 Professional Services
Feasibility Testing of GEC Specific AAV Vector (In Vivo Biodistribution and Transduction Efficacy Studies) 1 project $100,000.00 $100,000.00 Professional Services
Ex Vivo Immunofluorescent Validation 1 project $50,000.00 $50,000.00 Professional Services
Estimated Bid Value$450,000.00

Want the full details?

Sign up free to see the agency name and the original bid posting link, plus the 1 document, contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.

📎 36C24E27Q0009.docx View
Sign Up Free → Already have an account? Log in

Browse More Bids

Bids in PennsylvaniaInformation Technology BidsRFI BidsClosing Soon All Bids